Wang Anxin, Cao Shuang, Tian Xue, Zuo Yingting, Meng Xia, Chen Pan, Li Hao, Zhao Lu, Wang Yongjun
China National Clinical Research Center for Neurological Diseases, Advanced Innovation Center for Human Brain Protection, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Cerebrovasc Dis. 2022;51(3):304-312. doi: 10.1159/000520052. Epub 2021 Dec 2.
Serum potassium abnormality is a risk factor of incident stroke, but whether it is associated with recurrent stroke in patients with acute ischemic stroke (AIS) or transient ischemic attack (TIA) remains unknown. This study aimed to investigate the association of serum potassium with the risk of recurrent stroke in patients with AIS or TIA.
We included 12,425 patients from the China National Stroke Registry III. Patients were classified into 3 groups according to tertiles of potassium. The outcomes were recurrence of stroke and combined vascular events at 1 year. Cox proportional hazards regression was adopted to explore the associations by calculating hazard ratios (HRs) and their 95% confidence intervals (CIs).
Among 12,425 enrolled patients, the median (interquartile range) of potassium was 3.92 (3.68-4.19) mmol/L. Compared with the highest tertile, after adjusted for confounding factors, the lowest tertile potassium was associated with increased risk of recurrent stroke at 1 year. The adjusted HR with 95% CI was 1.21 (1.04-1.41). There was an independent, linear association between serum potassium and stroke recurrence. Per 1 mmol/L decrease of potassium was associated with 19% higher risk of recurrent stroke (HR, 1.19; 95% CI, 1.04-1.37). Similar trends were found in ischemic stroke and combined vascular events.
Lower serum potassium level was independently associated with elevated risk of recurrent stroke in patients with AIS or TIA. The finding suggested that monitoring serum potassium may help physicians to identify patients at high risk of recurrent stroke and to stratify risk for optimal management.
血清钾异常是新发卒中的一个危险因素,但在急性缺血性卒中(AIS)或短暂性脑缺血发作(TIA)患者中,其是否与卒中复发相关仍不清楚。本研究旨在探讨血清钾与AIS或TIA患者卒中复发风险之间的关联。
我们纳入了中国国家卒中登记系统III中的12425例患者。根据血钾三分位数将患者分为3组。结局指标为1年时的卒中复发和合并血管事件。采用Cox比例风险回归分析,通过计算风险比(HR)及其95%置信区间(CI)来探索关联。
在12425例纳入患者中,血钾的中位数(四分位间距)为3.92(3.68 - 4.19)mmol/L。与最高三分位数相比,在调整混杂因素后,最低三分位数血钾与1年时卒中复发风险增加相关。调整后的HR及其95%CI为1.21(1.04 - 1.41)。血清钾与卒中复发之间存在独立的线性关联。血钾每降低1 mmol/L,卒中复发风险增加19%(HR,1.19;95%CI,1.04 - 1.37)。在缺血性卒中和合并血管事件中也发现了类似趋势。
较低的血清钾水平与AIS或TIA患者卒中复发风险升高独立相关。这一发现表明,监测血清钾可能有助于医生识别卒中复发高危患者,并对风险进行分层以实现最佳管理。